Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2018 (2018), Article ID 5243617, 16 pages
https://doi.org/10.1155/2018/5243617
Research Article

A Toxicological Evaluation of a Standardized Hydrogenated Extract of Curcumin (CuroWhite™)

1Liveon Biolabs (P) Ltd., Tumkur, Karnataka 572106, India
2R&D Centre, Aurea Biolabs (P) Ltd., Kolenchery, Cochin, Kerala 682311, India

Correspondence should be addressed to Sreeraj Gopi; moc.sdipiltnalp@ipog.jareers and Tumkur Subbarao Jagannath; moc.sbaloibnoevil@htannagaj

Received 12 October 2017; Accepted 19 December 2017; Published 23 January 2018

Academic Editor: Syed Ali

Copyright © 2018 Alastimmanahalli Narasimhiah Ravikumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Sreeraj, J. Jacob, R. George, and T. R. Sreeraj, “A unique formulation of hydrogenated curcuminoids with higher bio availability and the application in food matrices,” Journal of Nutrition Food Sciences, vol. 6, no. 2, p. 1, 2016. View at Google Scholar
  2. A. Amalraj, A. Pius, S. Gopi, and S. Gopi, “Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A review,” Journal of Traditional and Complementary Medicine, vol. 7, no. 2, pp. 205–233, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Gopi, J. Jacob, and R. George, “Kinetic studies on the hydrogenation of curcuminoids isolated from Curcuma Longa by LC/MS,” Research Journal of Chemical Sciences, vol. 5, no. 4, pp. 33–36, 2015. View at Google Scholar
  4. C. Ireson, S. Orr, D. J. L. Jones et al., “Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production,” Cancer Research, vol. 61, no. 3, pp. 1058–1064, 2001. View at Google Scholar · View at Scopus
  5. J. S. Dempe, E. Pfeiffer, A. S. Grimm, and M. Metzler, “Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells,” Molecular Nutrition & Food Research, vol. 52, no. 9, pp. 1074–1081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Okada, C. Wangpoengtrakul, T. Tanaka, S. Toyokuni, K. Uchida, and T. Osawa, “Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice,” Journal of Nutrition, vol. 131, no. 8, pp. 2090–2095, 2001. View at Google Scholar · View at Scopus
  7. P. Murugan and L. Pari, “Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats,” Life Sciences, vol. 79, no. 18, pp. 1720–1728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Naito, X. Wu, H. Nomura et al., “The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits.,” Journal of Atherosclerosis and Thrombosis, vol. 9, no. 5, pp. 243–250, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Nakmareong, U. Kukongviriyapan, P. Pakdeechote et al., “Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 383, no. 5, pp. 519–529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. P. Dong, R. C. Yang, I. C. Chunag et al., “Inhibitory effect of hexahydrocurcumin on human platelet aggregation,” Natural Product Communication, vol. 7, no. 7, pp. 883-884, 2012. View at Google Scholar
  11. L. Pari and P. Murugan, “Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity,” Pharmacological Research, vol. 49, no. 5, pp. 481–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Rajeswari and M. Sabesan, “Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice,” Inflammopharmacology, vol. 16, no. 2, pp. 96–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Gopi, J. Jacob, and K. Y. Mathur, “Acute and subchronic oral toxicity studies of hydrogenated curcuminoid formulation ‘CuroWhite’ in rats,” Toxicology Reports, vol. 3, pp. 817–825, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. OECD, OECD Principles of Good Laboratory Practice (as revised in 1997) [C(97)186/FINAL], 1998.
  15. OECD, Test No. 471: Bacterial Reverse Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 1997.
  16. FDA, “Bacterial reverse mutation test,” in Redbook 2000, Toxicological Principles for the Safety Assessment of Food Ingredients, cahpter IV. C. 1. a., pp. 59–67, 2000. View at Google Scholar
  17. OECD, Test No. 473: In Vitro Mammalian Chromosomal Aberration Test, OECD Guidelines for the Testing of Chemicals, 1997.
  18. OECD, Test No. 474: Mammalian Erythrocyte Micronucleus Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 1997.
  19. OECD, Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, 1998.
  20. S. Balaji and B. Chempakam, “Toxicity prediction of compounds from turmeric (Curcuma longa L),” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2951–2959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. M. Holder, J. L. Plummer, and A. J. Ryan, “The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat,” Xenobiotica, vol. 8, no. 12, pp. 761–768, 1978. View at Publisher · View at Google Scholar · View at Scopus
  22. M.-H. Pan, T.-M. Huang, and J.-K. Lin, “Biotransformation of curcumin through reduction and glucuronidation in mice,” Drug Metabolism and Disposition, vol. 27, no. 4, pp. 486–494, 1999. View at Google Scholar · View at Scopus
  23. C. R. Ireson, D. J. Jones, S. Orr et al., “Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine,” Cancer epidemiology, biomarkers & prevention, vol. 11, no. 1, pp. 105–111, 2002. View at Google Scholar
  24. J. S. Dempe, R. K. Scheerle, E. Pfeiffer, and M. Metzler, “Metabolism and permeability of curcumin in cultured Caco-2 cells,” Molecular Nutrition & Food Research, vol. 57, no. 9, pp. 1543–1549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Jäger, R. P. Lowery, A. V. Calvanese, J. M. Joy, M. Purpura, and J. M. Wilson, “Comparative absorption of curcumin formulations,” Nutrition Journal , vol. 13, article 11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Sabinsa Corporation, “GRN 460, Curcumin Preparation - Curcumin C3 Complex® (and Agency Response Letter),” GRAS Notice Inventory, 2013.
  27. N. Juul Jensen, “Lack of mutagenic effect of turmeric oleoresin and curcumin in the Salmonella/mammalian microsome test,” Mutation Research Letters, vol. 105, no. 6, pp. 393–396, 1982. View at Publisher · View at Google Scholar · View at Scopus
  28. I. L. B. F. Vieira, D. C. P. de Souza, L. da Silva Coelho, L. C. Chen, and L. A. Guillo, “In vitro mutagenicity and blood compatibility of paclitaxel and curcumin in poly (dl-lactide-co-glicolide) films,” Toxicology in Vitro, vol. 27, no. 1, pp. 198–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. P. Araújo, F. Da Luz Dias, and C. S. Takahashi, “Potentiation by turmeric and curcumin of γ-radiation-induced chromosome aberrations in Chinese hamster ovary cells,” Teratogenesis, Carcinogenesis, and Mutagenesis, vol. 19, no. 1, pp. 9–18, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. C. P. Araújo, L. M. G. Antunes, and C. S. Takahashi, “Protective effect of thiourea, a hydroxyl-radical scavenger, on curcumin-induced chromosomal aberrations in an in vitro mammalian cell system,” Teratogenesis, Carcinogenesis, and Mutagenesis, vol. 21, no. 2, pp. 175–180, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Cao, L.-P. Jiang, Y. Liu, G. Yang, X.-F. Yao, and L.-F. Zhong, “Curcumin-induced genotoxicity and antigenotoxicity in HepG2 cells,” Toxicon, vol. 49, no. 8, pp. 1219–1222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Dandekar, R. Dhumal, R. Jain, D. Tiwari, G. Vanage, and V. Patravale, “Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2073–2089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Aggarwal, K. M. Chacko, and B. T. Kuruvilla, “Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: a bioavailable turmeric formulation,” Molecular Medicine Reports, vol. 13, no. 1, pp. 592–604, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. NTP, Toxicology and carcinogenesis studies of turmeric oleoresin, Research Triangle Park, NC: National Toxicology Program (NTP) U.S. Department of Health & Human Services (DHHS) Public Health Service (PHS), National Institutes of Health (NIH), 1993.
  35. C. Johnson and A. Mattia, Curcumin - WHO Food Additives Series: 35. WHO Food Additives Series, 2011.